JP6696782B2 - ビームフォーミング方法、計測イメージング装置、及び、通信装置 - Google Patents
ビームフォーミング方法、計測イメージング装置、及び、通信装置 Download PDFInfo
- Publication number
- JP6696782B2 JP6696782B2 JP2016013287A JP2016013287A JP6696782B2 JP 6696782 B2 JP6696782 B2 JP 6696782B2 JP 2016013287 A JP2016013287 A JP 2016013287A JP 2016013287 A JP2016013287 A JP 2016013287A JP 6696782 B2 JP6696782 B2 JP 6696782B2
- Authority
- JP
- Japan
- Prior art keywords
- wave
- signal
- reception
- transmission
- aperture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 876
- 238000005259 measurement Methods 0.000 title claims description 429
- 238000003384 imaging method Methods 0.000 title claims description 304
- 238000004891 communication Methods 0.000 title description 72
- 238000012545 processing Methods 0.000 claims description 822
- 230000005540 biological transmission Effects 0.000 claims description 597
- 230000008569 process Effects 0.000 claims description 286
- 230000009021 linear effect Effects 0.000 claims description 284
- 238000001228 spectrum Methods 0.000 claims description 204
- 238000006073 displacement reaction Methods 0.000 claims description 187
- 238000004364 calculation method Methods 0.000 claims description 182
- 238000001514 detection method Methods 0.000 claims description 151
- 230000015572 biosynthetic process Effects 0.000 claims description 138
- 238000003786 synthesis reaction Methods 0.000 claims description 137
- 230000000694 effects Effects 0.000 claims description 110
- 239000013598 vector Substances 0.000 claims description 73
- 238000009826 distribution Methods 0.000 claims description 71
- 230000003287 optical effect Effects 0.000 claims description 62
- 238000013508 migration Methods 0.000 claims description 57
- 230000005012 migration Effects 0.000 claims description 57
- 230000001965 increasing effect Effects 0.000 claims description 50
- 230000001427 coherent effect Effects 0.000 claims description 48
- 238000006243 chemical reaction Methods 0.000 claims description 40
- 230000033001 locomotion Effects 0.000 claims description 37
- 238000000926 separation method Methods 0.000 claims description 37
- 230000001902 propagating effect Effects 0.000 claims description 33
- 238000001914 filtration Methods 0.000 claims description 31
- 239000000126 substance Substances 0.000 claims description 31
- 238000011282 treatment Methods 0.000 claims description 31
- 238000012937 correction Methods 0.000 claims description 28
- 230000005855 radiation Effects 0.000 claims description 27
- 238000002604 ultrasonography Methods 0.000 claims description 27
- 239000002872 contrast media Substances 0.000 claims description 25
- 230000003595 spectral effect Effects 0.000 claims description 25
- 230000000704 physical effect Effects 0.000 claims description 20
- 239000011159 matrix material Substances 0.000 claims description 14
- 230000001133 acceleration Effects 0.000 claims description 13
- 230000003902 lesion Effects 0.000 claims description 13
- 238000003491 array Methods 0.000 claims description 12
- 230000004075 alteration Effects 0.000 claims description 11
- 238000003745 diagnosis Methods 0.000 claims description 10
- 238000010183 spectrum analysis Methods 0.000 claims description 10
- 238000012880 independent component analysis Methods 0.000 claims description 9
- 230000003044 adaptive effect Effects 0.000 claims description 8
- 238000013507 mapping Methods 0.000 claims description 8
- 230000007423 decrease Effects 0.000 claims description 7
- 230000004927 fusion Effects 0.000 claims description 6
- 238000010521 absorption reaction Methods 0.000 claims description 4
- 230000002452 interceptive effect Effects 0.000 claims description 4
- 238000013329 compounding Methods 0.000 claims description 3
- 238000002059 diagnostic imaging Methods 0.000 claims description 3
- 238000000513 principal component analysis Methods 0.000 claims description 3
- 238000000862 absorption spectrum Methods 0.000 claims description 2
- 230000006866 deterioration Effects 0.000 claims description 2
- 238000004148 unit process Methods 0.000 claims 2
- 238000004611 spectroscopical analysis Methods 0.000 claims 1
- 230000006870 function Effects 0.000 description 152
- 238000003860 storage Methods 0.000 description 122
- 230000009022 nonlinear effect Effects 0.000 description 69
- 230000014509 gene expression Effects 0.000 description 62
- 230000015654 memory Effects 0.000 description 62
- 238000010586 diagram Methods 0.000 description 50
- 238000007792 addition Methods 0.000 description 47
- 230000000875 corresponding effect Effects 0.000 description 46
- 238000005070 sampling Methods 0.000 description 46
- 210000001519 tissue Anatomy 0.000 description 44
- 230000008859 change Effects 0.000 description 43
- 230000007274 generation of a signal involved in cell-cell signaling Effects 0.000 description 35
- 239000000047 product Substances 0.000 description 34
- 238000010438 heat treatment Methods 0.000 description 29
- 230000002829 reductive effect Effects 0.000 description 27
- 230000010354 integration Effects 0.000 description 26
- 230000036961 partial effect Effects 0.000 description 20
- 230000005484 gravity Effects 0.000 description 18
- 238000005311 autocorrelation function Methods 0.000 description 17
- 238000002608 intravascular ultrasound Methods 0.000 description 17
- 239000000463 material Substances 0.000 description 17
- 230000004044 response Effects 0.000 description 17
- 238000004088 simulation Methods 0.000 description 17
- 239000013307 optical fiber Substances 0.000 description 16
- 239000006185 dispersion Substances 0.000 description 15
- 230000017531 blood circulation Effects 0.000 description 14
- 238000000691 measurement method Methods 0.000 description 14
- 230000004069 differentiation Effects 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- 230000010287 polarization Effects 0.000 description 13
- 206010028980 Neoplasm Diseases 0.000 description 12
- 201000011510 cancer Diseases 0.000 description 12
- 238000002156 mixing Methods 0.000 description 11
- 238000005481 NMR spectroscopy Methods 0.000 description 10
- 230000002441 reversible effect Effects 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- 230000006399 behavior Effects 0.000 description 9
- 230000006835 compression Effects 0.000 description 9
- 238000007906 compression Methods 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- 230000003321 amplification Effects 0.000 description 8
- 230000001934 delay Effects 0.000 description 8
- 238000012986 modification Methods 0.000 description 8
- 230000004048 modification Effects 0.000 description 8
- 238000003199 nucleic acid amplification method Methods 0.000 description 8
- 230000000644 propagated effect Effects 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 238000007689 inspection Methods 0.000 description 7
- 238000002600 positron emission tomography Methods 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 6
- 238000001069 Raman spectroscopy Methods 0.000 description 6
- 239000008272 agar Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000011065 in-situ storage Methods 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 230000008439 repair process Effects 0.000 description 6
- 238000001308 synthesis method Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 238000002592 echocardiography Methods 0.000 description 5
- 238000005457 optimization Methods 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 230000035939 shock Effects 0.000 description 5
- 210000004872 soft tissue Anatomy 0.000 description 5
- 238000012935 Averaging Methods 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 238000013459 approach Methods 0.000 description 4
- 238000004422 calculation algorithm Methods 0.000 description 4
- 238000002591 computed tomography Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000013500 data storage Methods 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 230000001066 destructive effect Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000005684 electric field Effects 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 230000004153 glucose metabolism Effects 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 238000012544 monitoring process Methods 0.000 description 4
- 230000000877 morphologic effect Effects 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 238000003672 processing method Methods 0.000 description 4
- 230000008685 targeting Effects 0.000 description 4
- 238000009966 trimming Methods 0.000 description 4
- 238000003466 welding Methods 0.000 description 4
- 241000238366 Cephalopoda Species 0.000 description 3
- 230000005355 Hall effect Effects 0.000 description 3
- 240000004050 Pentaglottis sempervirens Species 0.000 description 3
- 235000004522 Pentaglottis sempervirens Nutrition 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 210000005242 cardiac chamber Anatomy 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000007418 data mining Methods 0.000 description 3
- 230000003111 delayed effect Effects 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000009795 derivation Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 238000002595 magnetic resonance imaging Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000010295 mobile communication Methods 0.000 description 3
- 238000007781 pre-processing Methods 0.000 description 3
- 238000000518 rheometry Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 230000002194 synthesizing effect Effects 0.000 description 3
- 230000002123 temporal effect Effects 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- -1 urine Substances 0.000 description 3
- 241000282412 Homo Species 0.000 description 2
- 230000005374 Kerr effect Effects 0.000 description 2
- 238000012879 PET imaging Methods 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 238000009529 body temperature measurement Methods 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000000315 cryotherapy Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 239000002961 echo contrast media Substances 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000012216 imaging agent Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000009434 installation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000009607 mammography Methods 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 238000013421 nuclear magnetic resonance imaging Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000001028 reflection method Methods 0.000 description 2
- 239000004065 semiconductor Substances 0.000 description 2
- 238000004904 shortening Methods 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 238000003325 tomography Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000001131 transforming effect Effects 0.000 description 2
- ZCXUVYAZINUVJD-AHXZWLDOSA-N 2-deoxy-2-((18)F)fluoro-alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H]([18F])[C@@H](O)[C@@H]1O ZCXUVYAZINUVJD-AHXZWLDOSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- JBRZTFJDHDCESZ-UHFFFAOYSA-N AsGa Chemical compound [As]#[Ga] JBRZTFJDHDCESZ-UHFFFAOYSA-N 0.000 description 1
- 206010051290 Central nervous system lesion Diseases 0.000 description 1
- 102000018711 Facilitative Glucose Transport Proteins Human genes 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- 108091052347 Glucose transporter family Proteins 0.000 description 1
- 102000005548 Hexokinase Human genes 0.000 description 1
- 108700040460 Hexokinases Proteins 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000002583 angiography Methods 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- JRPBQTZRNDNNOP-UHFFFAOYSA-N barium titanate Chemical compound [Ba+2].[Ba+2].[O-][Ti]([O-])([O-])[O-] JRPBQTZRNDNNOP-UHFFFAOYSA-N 0.000 description 1
- 229910002113 barium titanate Inorganic materials 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000005266 beta plus decay Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 230000008822 capillary blood flow Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- QGJOPFRUJISHPQ-NJFSPNSNSA-N carbon disulfide-14c Chemical compound S=[14C]=S QGJOPFRUJISHPQ-NJFSPNSNSA-N 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 229910000428 cobalt oxide Inorganic materials 0.000 description 1
- IVMYJDGYRUAWML-UHFFFAOYSA-N cobalt(ii) oxide Chemical compound [Co]=O IVMYJDGYRUAWML-UHFFFAOYSA-N 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000005314 correlation function Methods 0.000 description 1
- 238000007428 craniotomy Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 description 1
- 229940011411 erythrosine Drugs 0.000 description 1
- 235000012732 erythrosine Nutrition 0.000 description 1
- 239000004174 erythrosine Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 238000001093 holography Methods 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000002582 magnetoencephalography Methods 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- FFEARJCKVFRZRR-JJZBXVGDSA-N methionine c-11 Chemical compound [11CH3]SCC[C@H](N)C(O)=O FFEARJCKVFRZRR-JJZBXVGDSA-N 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- NJPPVKZQTLUDBO-UHFFFAOYSA-N novaluron Chemical compound C1=C(Cl)C(OC(F)(F)C(OC(F)(F)F)F)=CC=C1NC(=O)NC(=O)C1=C(F)C=CC=C1F NJPPVKZQTLUDBO-UHFFFAOYSA-N 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000004038 photonic crystal Substances 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 239000012857 radioactive material Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 208000020352 skin basal cell carcinoma Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000679 solder Inorganic materials 0.000 description 1
- 229950001675 spiperone Drugs 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 238000010972 statistical evaluation Methods 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 238000005309 stochastic process Methods 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000004613 tight binding model Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Measurement Of Velocity Or Position Using Acoustic Or Ultrasonic Waves (AREA)
- Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Radar Systems Or Details Thereof (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015046528 | 2015-03-09 | ||
| JP2015046528 | 2015-03-09 | ||
| JP2015087901 | 2015-04-22 | ||
| JP2015087901 | 2015-04-22 | ||
| JP2015106798 | 2015-05-26 | ||
| JP2015106798 | 2015-05-26 | ||
| JP2015239409 | 2015-12-08 | ||
| JP2015239409 | 2015-12-08 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017104476A JP2017104476A (ja) | 2017-06-15 |
| JP2017104476A5 JP2017104476A5 (fr) | 2019-03-07 |
| JP6696782B2 true JP6696782B2 (ja) | 2020-05-20 |
Family
ID=59058195
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016013287A Active JP6696782B2 (ja) | 2015-03-09 | 2016-01-27 | ビームフォーミング方法、計測イメージング装置、及び、通信装置 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6696782B2 (fr) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023034465A3 (fr) * | 2021-09-02 | 2023-04-20 | Lyte Technologies Inc. | Systèmes de balayage à faisceaux multiples |
| US11977259B2 (en) | 2021-08-18 | 2024-05-07 | Lyte Ai, Inc. | Optical transceiver arrays |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11125866B2 (en) | 2015-06-04 | 2021-09-21 | Chikayoshi Sumi | Measurement and imaging instruments and beamforming method |
| EP3649960A4 (fr) * | 2017-07-04 | 2020-06-24 | FUJIFILM Corporation | Dispositif de diagnostic d'onde acoustique et procédé de fonctionnement d'un dispositif de diagnostic d'onde acoustique |
| EP3447525B1 (fr) * | 2017-08-23 | 2020-05-06 | Ecole Polytechnique Federale De Lausanne (Epfl) | Procédé de reconstruction d'image basée sur un modèle |
| JP2020039841A (ja) * | 2017-11-24 | 2020-03-19 | 炭 親良 | 計測イメージング装置 |
| CA3092123C (fr) | 2018-03-14 | 2021-12-07 | Mitsubishi Electric Corporation | Dispositif de traitement des images radar et procede de traitement des images radar |
| US11579288B2 (en) * | 2018-04-14 | 2023-02-14 | Coda Octopus Group Inc. | Pseudo random frequency sonar ping generation |
| CN112119327A (zh) * | 2018-05-15 | 2020-12-22 | 皇家飞利浦有限公司 | 具有声速像差映射的合成透射聚焦超声系统 |
| CN109709549A (zh) * | 2019-02-28 | 2019-05-03 | 电子科技大学 | 一种前视雷达超分辨率成像方法 |
| CN110261481B (zh) * | 2019-07-26 | 2023-12-12 | 招商局重庆公路工程检测中心有限公司 | 点压式采集装置 |
| CN111292222B (zh) * | 2020-01-22 | 2023-05-12 | 中国科学院新疆天文台 | 一种脉冲星消色散装置及方法 |
| US11474033B2 (en) | 2020-02-12 | 2022-10-18 | Canon Kabushiki Kaisha | Terahertz wave camera system and method for controlling terahertz wave camera system |
| CN112711018B (zh) * | 2020-12-17 | 2023-07-21 | 中国人民解放军军事科学院国防工程研究院工程防护研究所 | 一种近场空间网状结构聚焦波束形成方法 |
| CN113176572B (zh) * | 2021-04-27 | 2023-10-20 | 中山大学 | 一种基于环扫sar的海面波浪谱反演方法及系统 |
| WO2022264393A1 (fr) * | 2021-06-18 | 2022-12-22 | 三菱電機株式会社 | Dispositif de capteur optique |
| CN113938790B (zh) * | 2021-10-15 | 2023-12-22 | 江苏科技大学 | 一种声单向传播主控操控方法 |
| CN114726399B (zh) * | 2022-03-14 | 2023-05-23 | 中国电子科技集团公司第十研究所 | 一种非地面网络的空频二维跳频传输系统及传输方法 |
| WO2024023933A1 (fr) * | 2022-07-26 | 2024-02-01 | 日本電信電話株式会社 | Dispositif d'antenne |
| JP2024034190A (ja) * | 2022-08-31 | 2024-03-13 | パナソニックＩｐマネジメント株式会社 | レーダ装置 |
| CN116540238B (zh) * | 2022-09-07 | 2023-10-13 | 长江水利委员会水文局 | 基于测深数据及声学影像融合的水下岸坡工情监测方法 |
| CN115982571B (zh) * | 2023-01-12 | 2023-07-25 | 中国人民解放军军事科学院系统工程研究院 | 一种空间太赫兹通信信号的几何表示方法及装置 |
| CN116609742B (zh) * | 2023-06-05 | 2023-09-22 | 广州博远装备科技有限公司 | 基于实时地图反演sar回波模拟与干扰评估方法及系统 |
| CN116989888B (zh) * | 2023-09-27 | 2024-03-12 | 之江实验室 | 声成像方法、装置、计算机设备和存储介质 |
| CN117376977B (zh) * | 2023-12-07 | 2024-02-13 | 深圳市华粤世通软件科技有限公司 | 一种手机5g无线信号测试系统、方法、设备及介质 |
| CN117503203B (zh) * | 2024-01-03 | 2024-03-22 | 之江实验室 | 一种用于超声环阵成像的相位畸变校正方法和系统 |
-
2016
- 2016-01-27 JP JP2016013287A patent/JP6696782B2/ja active Active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11977259B2 (en) | 2021-08-18 | 2024-05-07 | Lyte Ai, Inc. | Optical transceiver arrays |
| WO2023034465A3 (fr) * | 2021-09-02 | 2023-04-20 | Lyte Technologies Inc. | Systèmes de balayage à faisceaux multiples |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017104476A (ja) | 2017-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6696782B2 (ja) | ビームフォーミング方法、計測イメージング装置、及び、通信装置 | |
| JP7175489B2 (ja) | ビームフォーミング方法、計測イメージング装置、及び、通信装置 | |
| US11965993B2 (en) | Measurement and imaging instruments and beamforming method | |
| US10624612B2 (en) | Beamforming method, measurement and imaging instruments, and communication instruments | |
| JP2020039841A (ja) | 計測イメージング装置 | |
| JP6408297B2 (ja) | ビームフォーミング方法、計測イメージング装置、及び、通信装置 | |
| US9084559B2 (en) | Imaging method, displacement measurement method and apparatus | |
| Bercoff | Ultrafast ultrasound imaging | |
| Hollender et al. | Single-and multiple-track-location shear wave and acoustic radiation force impulse imaging: matched comparison of contrast, contrast-to-noise ratio and resolution | |
| JP2017104476A5 (fr) | ||
| US8818064B2 (en) | Time-domain estimator for image reconstruction | |
| Porée et al. | A dual tissue-Doppler optical-flow method for speckle tracking echocardiography at high frame rate | |
| Favre et al. | Boosting transducer matrix sensitivity for 3D large field ultrasound localization microscopy using a multi-lens diffracting layer: a simulation study | |
| Hardy et al. | Sparse channel sampling for ultrasound localization microscopy (SPARSE-ULM) | |
| Zhang et al. | Partial Hadamard encoded synthetic transmit aperture for high frame rate imaging with minimal l 2-norm least squares method | |
| Fyleris et al. | Comparative analysis of plane-wave imaging and the total focusing method in the reconstruction of complex geometrical surfaces | |
| Pan et al. | Improving axial resolution based on the deconvolution recovery method combined with adaptive weighting techniques for ultrasound imaging | |
| JP6816898B2 (ja) | イメージング装置 | |
| McCall et al. | The development of a 1.25 MHz 1024-channel sparse array for human transcranial imaging: in vitro characterization | |
| Song et al. | Synthetic radial aperture focusing to regulate manual volumetric scanning for economic transrectal ultrasound imaging | |
| Sugioka et al. | Investigation on synthetic aperture imaging using focused transmit beams for cardiac ultrasonography | |
| JP7018671B2 (ja) | イメージング装置及び送信装置 | |
| Zhang et al. | Enhancing Row-column array (RCA)-based 3D ultrasound vascular imaging with spatial-temporal similarity weighting | |
| Dei | Model-Based Ultrasound Imaging for Challenging Acoustic Clutter Suppression | |
| Martiartu et al. | Pulse-echo ultrasound attenuation tomography |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20190128 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190128 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20191031 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191112 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20191225 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200306 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200414 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200423 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6696782 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |